# Accuray Inc: filings

ARAY · Nasdaq · CIK 1138723 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jun 30

Pages: [Overview](/companies/aray.md) · [Financials](/companies/aray/financials.md) · [Filings](/companies/aray/filings.md) · [Insiders](/companies/aray/insiders.md)

## Reports and events: 363 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 645, 8-K 265, SC 13G/A 80, 10-Q 53, 3 42, SC 13G 34, DEFA14A 23, S-8 23, DEF 14A 19, 10-K 18, SD 13, ARS 10, 425 9, 4/A 9, CT ORDER 9, 144 8, SCHEDULE 13G/A 8, UPLOAD 8, CORRESP 7, 3/A 5, 424B3 4, EFFECT 4, S-3 3, SCHEDULE 13D/A 3, SCHEDULE 13G 3, 10-K/A 2, 5 2, NT 10-K 2, PRE 14A 2, S-3/A 2, 10-Q/A 1, 144/A 1, 8-K/A 1, NT 10-Q 1, S-4 1, S-4/A 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-16 | 16:33 ET | [DEF 14A](/filings/0001140361-26-039918.md) | Proxy statement, period 2026-11-19 | 0001140361-26-039918 |
| 2026-10-13 | 16:03 ET | [8-K](/filings/0001437749-26-032558.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-032558 |
| 2026-10-06 | 16:02 ET | [8-K](/filings/0001437749-26-032174.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032174 |
| 2026-09-02 | 20:00 ET | [SCHEDULE 13D/A](/filings/0001104659-26-104846.md) | Ownership report, active investor, amended | 0001104659-26-104846 |
| 2026-08-27 | 16:02 ET | [10-K](/filings/0001437749-26-029098.md) | Annual report, period 2026-06-30 | 0001437749-26-029098 |
| 2026-08-24 | 16:02 ET | [DEF 14A](/filings/0001140361-26-034187.md) | Proxy statement, period 2026-10-06 | 0001140361-26-034187 |
| 2026-08-19 | 16:04 ET | [8-K](/filings/0001437749-26-028532.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-028532 |
| 2026-08-06 | 16:01 ET | [8-K](/filings/0001437749-26-026250.md) | 3.01 Delisting notice | 0001437749-26-026250 |
| 2026-07-29 | 17:25 ET | [8-K](/filings/0001437749-26-024904.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-024904 |
| 2026-06-04 | 16:02 ET | [8-K](/filings/0001437749-26-019558.md) | 1.02 Termination of a material agreement; 7.01 Regulation FD disclosure | 0001437749-26-019558 |
| 2026-05-22 | 15:57 ET | [SCHEDULE 13D/A](/filings/0001104659-26-065674.md) | Ownership report, active investor, amended | 0001104659-26-065674 |
| 2026-05-06 | 16:09 ET | [10-Q](/filings/0001437749-26-015199.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015199 |
| 2026-05-06 | 16:07 ET | [8-K](/filings/0001437749-26-015198.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015198 |
| 2026-04-28 | 09:00 ET | [8-K](/filings/0001437749-26-013543.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-013543 |
| 2026-04-17 | 06:03 ET | [SCHEDULE 13D/A](/filings/0001104659-26-044547.md) | Ownership report, active investor, amended | 0001104659-26-044547 |
| 2026-04-07 | 09:00 ET | [8-K](/filings/0001437749-26-011547.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-26-011547 |
| 2026-04-06 | 09:00 ET | [8-K](/filings/0001437749-26-011313.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-011313 |
| 2026-03-19 | 16:01 ET | [8-K](/filings/0001437749-26-009046.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-009046 |
| 2026-02-17 | 06:20 ET | [8-K](/filings/0001437749-26-004223.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-004223 |
| 2026-02-17 | 06:20 ET | [10-Q](/filings/0001437749-26-004221.md) | Quarterly report, period 2025-12-31 | 0001437749-26-004221 |
| 2026-02-17 | 06:18 ET | [10-Q/A](/filings/0001437749-26-004220.md) | Quarterly report, amended, period 2025-09-30 | 0001437749-26-004220 |
| 2026-02-17 | 06:17 ET | [10-K/A](/filings/0001437749-26-004219.md) | Annual report, amended, period 2025-06-30 | 0001437749-26-004219 |
| 2026-02-09 | 16:08 ET | [8-K](/filings/0001437749-26-003515.md) | 4.02 Non-reliance on financial statements | 0001437749-26-003515 |
| 2026-02-06 | 16:05 ET | [8-K](/filings/0001437749-26-003367.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001437749-26-003367 |
| 2026-02-04 | 16:05 ET | [8-K](/filings/0001437749-26-002976.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-002976 |
| 2026-01-20 | 17:00 ET | [8-K](/filings/0001193125-26-016769.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-016769 |
| 2025-12-31 | 16:05 ET | [8-K](/filings/0001437749-25-039074.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-25-039074 |
| 2025-12-16 | 06:02 ET | [8-K](/filings/0001193125-25-319896.md) | 1.01 Entry into a material agreement; 2.05 Exit or disposal costs; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-319896 |
| 2025-11-19 | 16:01 ET | [8-K](/filings/0001193125-25-288077.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-288077 |
| 2025-11-05 | 16:16 ET | [10-Q](/filings/0001193125-25-266985.md) | Quarterly report, period 2025-09-30 | 0001193125-25-266985 |
| 2025-11-05 | 16:11 ET | [8-K](/filings/0001193125-25-266940.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-266940 |
| 2025-10-20 | 09:20 ET | [8-K](/filings/0001193125-25-243143.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-243143 |
| 2025-10-01 | 16:02 ET | [DEF 14A](/filings/0001140361-25-036983.md) | Proxy statement, period 2025-11-13 | 0001140361-25-036983 |
| 2025-09-19 | 16:01 ET | [8-K](/filings/0001193125-25-209044.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-209044 |
| 2025-08-28 | 16:15 ET | [10-K](/filings/0001193125-25-191242.md) | Annual report, period 2025-06-30 | 0001193125-25-191242 |
| 2025-08-22 | 16:01 ET | [8-K](/filings/0001193125-25-186407.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-186407 |
| 2025-08-13 | 16:05 ET | [8-K](/filings/0001193125-25-179806.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-179806 |
| 2025-06-17 | 13:25 ET | [SCHEDULE 13D](/filings/0001104659-25-060187.md) | Ownership report, active investor | 0001104659-25-060187 |
| 2025-06-06 | 07:36 ET | [8-K](/filings/0000950103-25-007090.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-25-007090 |
| 2025-05-02 | 16:05 ET | [10-Q](/filings/0000950170-25-062744.md) | Quarterly report, period 2025-03-31 | 0000950170-25-062744 |
| 2025-04-30 | 16:10 ET | [8-K](/filings/0000950170-25-061055.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-061055 |
| 2025-02-07 | 16:01 ET | [8-K](/filings/0000950170-25-016249.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-016249 |
| 2025-02-05 | 16:15 ET | [10-Q](/filings/0000950170-25-014485.md) | Quarterly report, period 2024-12-31 | 0000950170-25-014485 |
| 2025-02-05 | 16:03 ET | [8-K](/filings/0000950170-25-014445.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-014445 |
| 2025-01-21 | 09:20 ET | [8-K](/filings/0000950170-25-007015.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-007015 |
| 2024-12-11 | 16:01 ET | [8-K](/filings/0001193125-24-275526.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-275526 |
| 2024-11-25 | 16:05 ET | [8-K](/filings/0000950170-24-130548.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-130548 |
| 2024-11-06 | 16:20 ET | [10-Q](/filings/0000950170-24-122358.md) | Quarterly report, period 2024-09-30 | 0000950170-24-122358 |
| 2024-11-06 | 16:10 ET | [8-K](/filings/0000950170-24-122304.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-122304 |
| 2024-10-21 | 16:10 ET | [8-K](/filings/0000950170-24-115941.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-115941 |

Page 1 of 8. [Older](/companies/aray/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:06 ET. No prices; not investment advice.